Dr. Hossam Nada, Dongguk University, South Korea
🎓 Dr. Hossam Nada is a distinguished scholar in Medicinal Chemistry, holding a Ph.D. from Dongguk University, South Korea. He has further honed his expertise with an M.A. in Pharmaceutical Sciences and a Bachelor of Pharmacy from Cairo University. Currently serving as a Postdoctoral Fellow at Dongguk University, Goyang-si, South Korea, Dr. Nada has previously undertaken roles as a Graduate Researcher and Assistant Lecturer. His academic journey is adorned with accolades, including the Korean Government Scholarship and Dongguk University Research Excellence Award, underscoring his commitment to excellence in research and academia. 🏆🔬
🌐 Professional Profile:
Scopus
Orcid
👨🎓 Education:
- Ph.D. in Medicinal Chemistry from Dongguk University (2023)
- M.A. in Pharmaceutical Sciences from Cairo University (2018)
- Bachelor of Pharmacy from Cairo University (2012)
💼 Experience:
- Postdoctoral Fellow: Dongguk University, Goyang-si, South Korea (09/2023 – Present)
- Graduate Researcher: Dongguk University, Goyang-si, South Korea (09/2020 – 08/2023)
- Assistant Lecturer: Badr University, Cairo (09/2017 – 08/2019)
- Teaching Assistant: Helioplis University, Cairo (09/2014 – 08/2017)
🏆 Awards and Grants:
- Korean Government Scholarship (2019-2023)
- Dongguk University Research Excellence Award (2023)
- Korean Government Best Academic Performance Award (2022, 2021)
- Dongguk Univ. Research Fund of 2023
Publication Top Notes:
- Small Molecule c-KIT Inhibitors for the Treatment of Gastrointestinal Stromal Tumors: A Review on Synthesis, Design Strategies, and Structure–Activity Relationship (SAR)
- Published in International Journal of Molecular Sciences, 2023.
- Citations: 2
- Design, Synthesis and Biological Evaluation of Novel MDH Inhibitors Targeting Tumor Microenvironment
- Published in Pharmaceuticals, 2023.
- Citations: 1
- Perspective for Discovery of Small Molecule IL-6 Inhibitors through Study of Structure-Activity Relationships and Molecular Docking
- Published in Journal of Medicinal Chemistry, 2023.
- Citations: 9
- Discovery and optimization of natural-based nanomolar c-Kit inhibitors via in silico and in vitro studies
- Published in Journal of Biomolecular Structure and Dynamics, 2023.
- Citations: 6
- Novel cudraisoflavone J derivatives as potent neuroprotective agents for the treatment of Parkinson’s disease via the activation of Nrf2/HO-1 signaling
- Published in European Journal of Medicinal Chemistry, 2022.
- Citations: 1